GB8622618D0 - Treatment of obesity - Google Patents

Treatment of obesity

Info

Publication number
GB8622618D0
GB8622618D0 GB868622618A GB8622618A GB8622618D0 GB 8622618 D0 GB8622618 D0 GB 8622618D0 GB 868622618 A GB868622618 A GB 868622618A GB 8622618 A GB8622618 A GB 8622618A GB 8622618 D0 GB8622618 D0 GB 8622618D0
Authority
GB
United Kingdom
Prior art keywords
diet
tryptophan
daily
composition
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB868622618A
Other versions
GB2180747A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Krietzman S N
Original Assignee
Krietzman S N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krietzman S N filed Critical Krietzman S N
Publication of GB8622618D0 publication Critical patent/GB8622618D0/en
Publication of GB2180747A publication Critical patent/GB2180747A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Treatment of obesity, especially in man. In the invention an overweight patient is given a daily diet in which the amount of proteinaceous material is restricted below the patient's normal average daily intake of protein, together with a daily dose of at least about 0.5 grams of L-tryptophan as appetite-suppressant. Thus, the invention provides a composition for use in the treatment of obesity. That composition comprises L-tryptophan and a protein-restricted diet composition as carrier, the amount of L-tryptophan in the composition being such as to provide at least about 0.5 grams of L-tryptophan per daily amount of diet. Preferably, the carrier is a protein-restricted formula diet, the diet comprising on a daily amount basis less than about 100 grams of proteinaceaous material and an energy level of no more than about 1000 Kcals.
GB08622618A 1985-09-20 1986-09-19 Tryptophan composition for treatment of obesity Withdrawn GB2180747A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858523338A GB8523338D0 (en) 1985-09-20 1985-09-20 Treatment of obesity

Publications (2)

Publication Number Publication Date
GB8622618D0 true GB8622618D0 (en) 1986-10-22
GB2180747A GB2180747A (en) 1987-04-08

Family

ID=10585524

Family Applications (2)

Application Number Title Priority Date Filing Date
GB858523338A Pending GB8523338D0 (en) 1985-09-20 1985-09-20 Treatment of obesity
GB08622618A Withdrawn GB2180747A (en) 1985-09-20 1986-09-19 Tryptophan composition for treatment of obesity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB858523338A Pending GB8523338D0 (en) 1985-09-20 1985-09-20 Treatment of obesity

Country Status (3)

Country Link
EP (1) EP0238533A1 (en)
GB (2) GB8523338D0 (en)
WO (1) WO1987001590A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2648044A1 (en) * 1989-06-07 1990-12-14 Norchim Liquid pharmaceutical composition exhibiting anorexigenic activity
FR2657013B1 (en) * 1990-01-18 1992-05-15 Medgenix Group Sa DIETETIC COMPOSITION BASED ON POLYPEPTIDES AND AMINO ACIDS.
ES2087027B1 (en) * 1994-08-03 1997-02-01 Univ Illes Balears NUTRITIONAL THERMOGENETIC SUPPLEMENTS, FOODS THAT CONTAIN THEM AND APPLICATIONS.
GB9416921D0 (en) * 1994-08-22 1994-10-12 Conway Gitta C A nutritional preparation
US6013622A (en) * 1998-04-15 2000-01-11 Nutriceutical Technology Corporation Method of regulating appetite and metabolism
FR2777751B1 (en) * 1998-04-23 2001-11-02 Pro Dietic Rdp PROTEIN SUPPLEMENT, FOOD COMPOSITION CONTAINING THE SAME, PROCESS FOR THEIR PREPARATION AND THEIR USE.
DE69937396T2 (en) * 1998-04-23 2008-07-24 Pro Dietic Rdp (S.A.R.L.) IDEA COMPOSITION, FOOD PREPARATION CONTAINING THEREOF, METHOD FOR THE PRODUCTION THEREOF AND THE APPLICATION THEREOF
US6132724A (en) * 1998-04-29 2000-10-17 City Of Hope National Medical Center Allelic polygene diagnosis of reward deficiency syndrome and treatment
ATE228779T1 (en) * 1999-01-20 2002-12-15 Nutricia Nv INFANT NUTRITIONAL PREPARATION
DK1153548T3 (en) 2000-05-12 2007-09-10 Nattopharma Asa Food product containing vitamin k2
GB0220182D0 (en) 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
AU2003207417A1 (en) * 2003-02-07 2004-08-30 Campina B.V. Use of tryptophan rich peptides
ITTO20070391A1 (en) * 2007-06-05 2008-12-06 Medestea Res & Production S P COMPOSITION OF FOOD SUPPLEMENT, DRUG OR MEDICAL DEVICE AND ITS USE TO SUPPRESS THE APPETITE, IMPROVING TONE AND HUMOR, WITH NATURAL ANTIDEPRESSIVE ACTIVITY AND ANTI-STASTENIC EFFECT
CA3037228A1 (en) * 2016-09-29 2018-04-05 Nestec S.A. Methods that reduce food cravings, promote weight loss, and/or treat overweight or obesity
CN114631629A (en) * 2020-12-15 2022-06-17 中国科学院上海营养与健康研究所 A method for treating obesity with low protein content

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150044A (en) * 1962-04-18 1964-09-22 Sam I Stein Treatment and composition for high blood pressure and palpitation
GB1289096A (en) * 1968-10-03 1972-09-13
US3809752A (en) * 1971-03-24 1974-05-07 W Fishman Anti-obesity process
DE2305209A1 (en) * 1972-02-14 1973-08-23 Hoffmann La Roche PHARMACEUTICAL PREPARATION
US4298601A (en) * 1972-03-06 1981-11-03 Technutra, S.A. Method and formulations for the treatment of obesity
GB1356370A (en) * 1972-03-06 1974-06-12 Howard A N Methods and formulations for the treatment of obesity
US4042687A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of treating obesity by the oral administration of a predigested protein composition
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
US4377595A (en) * 1979-08-13 1983-03-22 Massachusetts Institute Of Technology Process for reducing depression
DK198583A (en) * 1982-05-20 1983-11-21 Showa Denko Kk PIG FEED
GB2129299A (en) * 1982-11-09 1984-05-16 Alec James Coppen Pharmaceutical compositions
CH658165A5 (en) * 1984-01-04 1986-10-31 Nestle Sa FOOD PRODUCT EFFECTIVE IN THE TREATMENT OF LEPROSY.

Also Published As

Publication number Publication date
WO1987001590A1 (en) 1987-03-26
GB8523338D0 (en) 1985-10-23
GB2180747A (en) 1987-04-08
EP0238533A1 (en) 1987-09-30

Similar Documents

Publication Publication Date Title
GB8622618D0 (en) Treatment of obesity
NZ334635A (en) Treatment of autoimmune diseases such as rheumatoid arthritis with a vaccine
AU678795B2 (en) Application of riluzole in the treatment of neurological lesions related to traumatic injuries
GR3036901T3 (en) Treatment of partial growth hormone insensitivity syndrome
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
AU4632685A (en) Dietary supplement and method of minimizing effects of infection through diet
CA2029420A1 (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
AU697311B2 (en) Combined preparation for the therapy of immunological diseases
EP0342956A3 (en) Use of phytic acid or its salts for the treatment of hyperlipemia, obesity and obesity-related diseases
EA200000506A1 (en) COMPOSITION TO REDUCE WEIGHT
PL325865A1 (en) Selective antagonists of beta3-adrenergic receptor
ATE127020T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING EGG SHELL INGREDIENTS AND THEIR PREPARATION AND USE.
ZA895840B (en) N-2,3-butadienyl tri-and tetraaminoalkane derivatives
GR3032041T3 (en) Idebenone compositions for treating Alzheimer's disease.
GR3003750T3 (en)
GB8402573D0 (en) Oral formulation
EP0167995A3 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
JPS57126420A (en) Drug for digestive organ
AU8230187A (en) N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
SG49239A1 (en) Amylin and possibly insulin containing composition for the treatment of aneroxia and related states
EP0946174A4 (en) Treatment of urinary incontinence and compositions for use therein
GB9617611D0 (en) Treatment of autoimmune disease
BG49742A1 (en) Affrodisiance means
UA10249A (en) Method for treating diabetic angiopathy
GR950100380A (en) Natural ointment for pharmaceutical and cosmetical use

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)